Article ID Journal Published Year Pages File Type
2928856 International Journal of Cardiology 2016 6 Pages PDF
Abstract

AimsThere is uncertainty on which stenting approach confers the best long-term outlook for unprotected left main (ULM) bifurcation disease.Methods and resultsThis is a non-randomized, retrospective study including all consecutive patients with 50% stenosis of the left main involving at least 1 of the arteries stemming from the left main treated with drug-eluting stents (DES) in 9 European centers between 2002 and 2004. Patients were divided into two groups: those treated with provisional stentings vs. those treated with two stent strategy. The outcomes of interest were 10-year rates of target lesion revascularization (TLR), major adverse cardiac events (MACE), and their components (cardiovascular death, myocardial infarction [MI], or repeat revascularization), along with stent thrombosis (ST). A total of 285 patients were included, 178 (62.5%) in the provisional stenting group and 87 (37.5%) in the two stent group. After 10 years, no differences in TLR were found at unadjusted analysis (19% vs 25%, p > 0.05) nor after propensity score matching (25% vs 28%, p > 0.05). Similar rates of MACE (60% vs 66%, p > 0.05), death (34% vs 43%, p > 0.05), MI (9% vs 14%, p > 0.05) and ST were also disclosed at propensity-based analysis.ConclusionEven after 10 year follow-up, patients treated with provisional stenting on left main showed comparable rates of target lesion revascularization compared to two stent strategy.

Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , , , , , , ,